Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Two cases of severe liver injuries induced by acetaminophen].

Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine·1992
Same author

Yolk vitronectin. Purification and differences from its blood homologue in molecular size, heparin binding, collagen binding, and bound carbohydrate.

The Journal of biological chemistry·1992
Same author

Evaluation of the micronucleus test using a Chinese hamster cell line as an alternative to the conventional in vitro chromosomal aberration test.

Mutation research·1992
Same author

Enhanced production of platelet-activating factor in stimulated rat leukocytes pretreated with triacsin C, A novel acyl-coA synthetase inhibitor.

Biochemical and biophysical research communications·1992
Same author

[A case of progressive supranuclear palsy presenting mouth opening difficulty with tonic contraction of the orbicularis oris muscle].

Rinsho shinkeigaku = Clinical neurology·1992
Same author

3,5-Dihydroxyphenyl-glycine: a potent agonist of metabotropic glutamate receptors.

Neuroreport·1992

Related Experiment Video

Updated: Jul 16, 2026

Turbidimetry on Human Washed Platelets: The Effect of the Pannexin1-inhibitor Brilliant Blue FCF on Collagen-induced Aggregation
09:13

Turbidimetry on Human Washed Platelets: The Effect of the Pannexin1-inhibitor Brilliant Blue FCF on Collagen-induced Aggregation

Published on: April 6, 2017

Platelet aggregation and adenosine triphosphate secretion after laparotomy.

M Hayashi1

  • 1Department of Obstetrics and Gynecology, Koshigaya Hospital, Dokkyo University School of Medicine, 2-1-50, Minami-Koshigaya, Koshigaya-shi, Saitama 343-8555, Japan. mhayashi@lilac.plala.or.jp

Journal of Medicine
|February 23, 2007
PubMed
Summary

Laparotomy surgery temporarily reduces platelet count and volume. Post-surgery, platelet aggregation increases, while adenosine triphosphate (ATP) secretion varies depending on the stimulant used.

More Related Videos

Dynamic Multiparameter Platelet Function Assessment Using a Capacitive Biosensor
06:32

Dynamic Multiparameter Platelet Function Assessment Using a Capacitive Biosensor

Published on: May 2, 2025

Platelet Adhesion and Aggregation Under Flow using Microfluidic Flow Cells
10:10

Platelet Adhesion and Aggregation Under Flow using Microfluidic Flow Cells

Published on: October 27, 2009

Related Experiment Videos

Last Updated: Jul 16, 2026

Turbidimetry on Human Washed Platelets: The Effect of the Pannexin1-inhibitor Brilliant Blue FCF on Collagen-induced Aggregation
09:13

Turbidimetry on Human Washed Platelets: The Effect of the Pannexin1-inhibitor Brilliant Blue FCF on Collagen-induced Aggregation

Published on: April 6, 2017

Dynamic Multiparameter Platelet Function Assessment Using a Capacitive Biosensor
06:32

Dynamic Multiparameter Platelet Function Assessment Using a Capacitive Biosensor

Published on: May 2, 2025

Platelet Adhesion and Aggregation Under Flow using Microfluidic Flow Cells
10:10

Platelet Adhesion and Aggregation Under Flow using Microfluidic Flow Cells

Published on: October 27, 2009

Area of Science:

  • Hematology
  • Surgical Research
  • Biochemistry

Background:

  • Platelets play a crucial role in hemostasis and inflammation.
  • Surgical procedures like laparotomy can impact hemostatic function.
  • Understanding post-operative changes in platelet parameters is vital for patient management.

Purpose of the Study:

  • To investigate the dynamic changes in platelet count, mean platelet volume, aggregation, and adenosine triphosphate (ATP) secretion following laparotomy.
  • To assess the impact of laparotomy on platelet function using different activation pathways.

Main Methods:

  • Peripheral blood samples were collected from 32 gynecological patients pre-operatively, one day post-operatively, and two weeks post-operatively.
  • Platelet count and mean platelet volume were analyzed.
  • Platelet aggregation and ATP secretion were measured using a lumiaggregometer with adenosine diphosphate (ADP) and collagen as agonists.

Main Results:

  • Platelet count was significantly decreased one day after laparotomy compared to pre-operation.
  • Mean platelet volume was significantly lower at two weeks post-laparotomy compared to pre-operation and one day post-operation.
  • Platelet aggregation induced by ADP increased significantly two weeks after laparotomy.
  • ATP secretion induced by collagen was significantly reduced one day after laparotomy, while ADP-induced ATP secretion showed no significant difference.

Conclusions:

  • Laparotomy induces significant alterations in platelet parameters, including decreased count and volume, and altered aggregation and secretion patterns.
  • The differential response in ATP secretion suggests distinct platelet activation pathways may be affected differently by surgery.
  • These findings highlight the complex impact of laparotomy on platelet function and warrant further investigation into the clinical implications.